GlassScriptPhysician profile
Jerry M Adam
NPI 1932194396
$915.35
in general payments reported to CMS, 2019-2025
14 companies · $517 in 2025
The $517 reported for 2025 was more than what 97% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $84.79 · 2022: $136 · 2023: $53.04 · 2024: $125 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $694.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $270.20 | 2021-2025 | Entyvio, Eohilia |
| Aimmune Therapeutics, INC. | $140.82 | 2024-2025 | Zenpep |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $98.62 | 2021-2025 | Xifaxan |
| Madrigal Pharmaceuticals | $83.48 | 2025 | Rezdiffra |
| Celltrion USA INC. | $79.85 | 2024-2025 | Vegzelma |
| Phathom Pharmaceuticals, INC. | $48.02 | 2025 | Voquezna |
| Intercept Pharmaceuticals, INC. | $46.79 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $25.45 | 2025 | Dupixent |
| Nestle Healthcare Nutrition INC. | $25.11 | 2021 | |
| Ardelyx, INC. | $21.26 | 2025 | Ibsrela |
| Merck Sharp & Dohme LLC | $20.55 | 2023 | Dificid |
| Abbvie INC. | $18.89 | 2022 | |
| Braintree Laboratories, INC. | $18.27 | 2022 | |
| Lilly USA, LLC | $18.04 | 2024 | Omvoh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Adam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.